Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Etoposide | 0.1 | uM | 3 | 312.50 | 257.33 | 415.00 | 469.25 | 0.8844 | 0.7357 |
| SK-BR-3 | NVP-TAE684 | 0.031623 | uM | 3 | 312.50 | 257.33 | 464.00 | 469.25 | 0.9888 | 0.9742 |
| SK-BR-3 | 0 | uM | 3 | 312.50 | 257.33 | 458.00 | 469.25 | 0.9760 | 0.9448 | |
| SK-BR-3 | 0 | uM | 3 | 312.50 | 257.33 | 237.00 | 469.25 | 0.5051 | -0.0906 | |
| SK-BR-3 | 0 | uM | 3 | 312.50 | 257.33 | 337.00 | 469.25 | 0.7182 | 0.3650 | |
| SK-BR-3 | 0 | uM | 3 | 312.50 | 257.33 | 370.00 | 469.25 | 0.7885 | 0.5204 | |
| SK-BR-3 | PLX-4720 | 19.9526 | uM | 3 | 312.50 | 257.33 | 352.00 | 469.25 | 0.7501 | 0.4354 |
| SK-BR-3 | Nilotinib | 3.1623 | uM | 3 | 312.50 | 257.33 | 401.00 | 469.25 | 0.8546 | 0.6683 |
| SK-BR-3 | Etoposide | 0.0033113 | uM | 3 | 312.50 | 257.33 | 474.00 | 469.25 | 1.0101 | 1.0234 |
| SK-BR-3 | Etoposide | 0.031623 | uM | 3 | 312.50 | 257.33 | 438.00 | 469.25 | 0.9334 | 0.8471 |
| SK-BR-3 | PLX-4720 | 0.031623 | uM | 3 | 312.50 | 257.33 | 541.00 | 469.25 | 1.1529 | 1.3568 |
| SK-BR-3 | Nilotinib | 0.31623 | uM | 3 | 312.50 | 257.33 | 582.00 | 469.25 | 1.2403 | 1.5641 |
| SK-BR-3 | NVP-TAE684 | 0.0033113 | uM | 3 | 312.50 | 257.33 | 523.00 | 469.25 | 1.1145 | 1.2666 |
| SK-BR-3 | PLX-4720 | 0.1 | uM | 3 | 312.50 | 257.33 | 486.00 | 469.25 | 1.0357 | 1.0826 |
| SK-BR-3 | NVP-TAE684 | 0.1 | uM | 3 | 312.50 | 257.33 | 583.00 | 469.25 | 1.2424 | 1.5692 |
| SK-BR-3 | NVP-TAE684 | 0.01 | uM | 3 | 312.50 | 257.33 | 542.00 | 469.25 | 1.1550 | 1.3618 |
| SK-BR-3 | 0 | uM | 3 | 312.50 | 257.33 | 537.00 | 469.25 | 1.1444 | 1.3367 | |
| SK-BR-3 | Nilotinib | 0.01 | uM | 3 | 312.50 | 257.33 | 534.00 | 469.25 | 1.1380 | 1.3217 |
| SK-BR-3 | 0 | uM | 3 | 312.50 | 257.33 | 495.00 | 469.25 | 1.0549 | 1.1272 | |
| SK-BR-3 | NVP-TAE684 | 0.31623 | uM | 3 | 312.50 | 257.33 | 472.00 | 469.25 | 1.0059 | 1.0135 |
| SK-BR-3 | Etoposide | 0.01 | uM | 3 | 312.50 | 257.33 | 457.00 | 469.25 | 0.9739 | 0.9399 |
| SK-BR-3 | Etoposide | 1 | uM | 3 | 312.50 | 257.33 | 285.00 | 469.25 | 0.6074 | 0.1250 |
| SK-BR-3 | PLX-4720 | 10 | uM | 3 | 312.50 | 257.33 | 408.00 | 469.25 | 0.8695 | 0.7019 |
| SK-BR-3 | Etoposide | 10 | uM | 3 | 312.50 | 257.33 | 240.00 | 469.25 | 0.5115 | -0.0773 |
| SK-BR-3 | Nilotinib | 0.0033113 | uM | 3 | 312.50 | 257.33 | 532.00 | 469.25 | 1.1337 | 1.3116 |